Results
Samrat Pharmachem FY26 Net Loss of ₹3.31 Crore
Samrat Pharmachem reported a net loss of ₹3.31 crore for FY26, a significant decline from a ₹7.11 crore profit in FY25, with revenue up 1% to ₹289.72 crore.
The company will hold its 34th AGM on Septe
